Apollomics Inc.
APLM · XNASCIK 1944885fmd_1C5FC9VTXWQ6WJVK6TYF5VHE0FManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2025, 9 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Operating income
- 1
- Net income
- (54)
- Free cash flow
- (29)
Daily close · APLMIEX trades only
Jul 09, 2024 to Oct 28, 2026 · 250 sessions19.65 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
Apollomics Inc. (APLM) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 20-F 2025-04-03 · proof | |
| Net income | -$53.9 million | -$172.6 million | 20-F 2025-04-03 · proof | |
| Cash from operating activities | -$28.7 million | -$43.2 million | 20-F 2025-04-03 · proof | |
| Free cash flow | -$28.8 million | -$43.2 million | 20-F 2025-04-03 · proof | |
| Total assets | $13.1 million | $55.4 million | -76.4% | 20-F 2025-04-03 · proof |
| Cash and cash equivalents | $9.8 million | $32.1 million | -69.5% | 20-F 2025-04-03 · proof |
- What was Apollomics Inc. (APLM)'s revenue in fiscal 2024?
- Apollomics Inc. (APLM) reported revenue of $0 for fiscal 2024 (the year ended Dec 31, 2024), against $0 the year before. Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
- What was Apollomics Inc. (APLM)'s net income in fiscal 2024?
- Apollomics Inc. (APLM) reported net income of -$53.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$172.6 million the year before. Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
- What was Apollomics Inc. (APLM)'s cash from operating activities in fiscal 2024?
- Apollomics Inc. (APLM) reported cash from operating activities of -$28.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$43.2 million the year before. Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
- What was Apollomics Inc. (APLM)'s free cash flow in fiscal 2024?
- Apollomics Inc. (APLM) reported free cash flow of -$28.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$43.2 million the year before. Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
- What are Apollomics Inc. (APLM)'s total assets?
- As of Dec 31, 2024, Apollomics Inc. (APLM) reported total assets of $13.1 million, against $55.4 million a year earlier (-76.4%). Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
- What are Apollomics Inc. (APLM)'s cash and cash equivalents?
- As of Dec 31, 2024, Apollomics Inc. (APLM) reported cash and cash equivalents of $9.8 million, against $32.1 million a year earlier (-69.5%). Source: the 20-F filed with the SEC on Apr 3, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:APLM&period_type=annual&limit=5"Information only, not investment advice.